Literature DB >> 27519625

Application of CRISPR-Cas system in gene therapy: Pre-clinical progress in animal model.

Lihong Guan1, Yawei Han2, Shaoyi Zhu3, Juntang Lin4.   

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPRs) and their associated proteins (Cas) belong to the crucial adaptive immune system, which exist in archaea and bacteria. Currently, CRISPR-Cas9 system has been modified and widely used to edit genome. In this review, we summarized the discovery, classification and mechanism of CRISPR-Cas system and further discussed the application of CRISPR-Cas9 in gene therapy, mainly in disease models.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  CRISPR-Cas9; DNA repair; Disease model; Gene therapy; Genome editing

Mesh:

Substances:

Year:  2016        PMID: 27519625     DOI: 10.1016/j.dnarep.2016.07.004

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  3 in total

1.  Gene-specific MicroRNA antagonism protects against HIV Tat and TGF-β-mediated suppression of CFTR mRNA and function.

Authors:  R K Dutta; S Chinnapaiyan; M J Santiago; I Rahman; H J Unwalla
Journal:  Biomed Pharmacother       Date:  2021-08-27       Impact factor: 7.419

2.  Arabidopsis glutamate:glyoxylate aminotransferase 1 (Ler) mutants generated by CRISPR/Cas9 and their characteristics.

Authors:  Yaping Liang; Xiuying Zeng; Xinxiang Peng; Xuewen Hou
Journal:  Transgenic Res       Date:  2018-02-01       Impact factor: 2.788

3.  Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection.

Authors:  Antón Ambroa; Lucia Blasco; María López; Olga Pacios; Inés Bleriot; Laura Fernández-García; Manuel González de Aledo; Concha Ortiz-Cartagena; Andrew Millard; María Tomás
Journal:  Front Microbiol       Date:  2022-02-17       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.